(Q39633452)

13 September 2017

0 references

Effective Treatment of Intestinal Behçet's Disease with Long-Term, Low-Dose Clarithromycin (English)

1 reference

13 September 2017

0 references

Yukiya Hakozaki

1

1 reference

13 September 2017

Keiji Mitani

2

1 reference

13 September 2017

Chizuko Okada

3

1 reference

13 September 2017

Hisato Terada

4

1 reference

13 September 2017

Shinichi Kobari

5

1 reference

13 September 2017

language of work or name

1 reference

1 January 2013

1 reference

Case reports in gastroenterology

13 September 2017

1 reference

13 September 2017

7

1 reference

13 September 2017

1

1 reference

13 September 2017

122-126

1 reference

Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings.

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Long-term macrolide therapy in chronic inflammatory airway diseases.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

EULAR recommendations for the management of Behçet disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Efficacy of infliximab for induction and maintenance of remission in intestinal Behçet's disease

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Open label trial of oral clarithromycin in active Crohn's disease.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3617967

Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome?

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23626512

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000350320

1 reference

13 September 2017

1 reference

13 September 2017

1 reference